| All Releases |
 |
June 26, 2009
Warner Chilcott to Hold 2009 Annual General Meeting of Shareholders and Special Court-Ordered Meeting of Shareholders |
 |
 |
| |
ARDEE, Ireland, June 26, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited announced today that it will hold its 2009 Annual General Meeting of Shareholders (the "Annual Meeting") and a Special Court-Ordered Meeting of Shareholders (the "Special Meeting") on August 5, 2009. At the Special Meeting, the Company's shareho... |
|
|
June 19, 2009
Warner Chilcott to Present at Wachovia's 19th Annual Mid-Year Equity Conference |
|
|
| |
ARDEE, Ireland, June 19, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will present at Wachovia's 19th Annual Mid-Year Equity Conference on Wednesday, June 24, 2009 at 2:30 p.m. ET. Presenting for Warner Chilcott will be Rochelle Fuhrmann, Senior Director, Investor Relations.
... |
|
|
June 8, 2009
Warner Chilcott to Present at the Goldman Sachs 30th Annual Healthcare Conference |
|
|
| |
ARDEE, Ireland, June 8, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will present at the Goldman Sachs 30th Annual Healthcare Conference on Wednesday, June 10, 2009 at 10:20 a.m. ET. Presenting for Warner Chilcott will be Roger Boissonneault, President and Chief Executive Off... |
|
|
May 27, 2009
Warner Chilcott Announces FDA Acceptance of NDA Submission for Low Dose Oral Contraceptive |
|
|
| |
ARDEE, Ireland, May 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that the U.S. Food and Drug Administration (FDA) has filed for standard review the new drug application (NDA) for WC 3016, a low dose oral contraceptive. The NDA for WC 3016 was submitted by its subsidiary, Warner C... |
|
|
May 11, 2009
Warner Chilcott Proposes Redomestication From Bermuda to Ireland |
|
|
| |
ARDEE, Ireland, May 11, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced that its Board of Directors has unanimously approved the redomestication of the Company from Bermuda to Ireland. Subject to the approval of a scheme of arrangement by the Company's stockholders and the approval of th... |
|
|
May 11, 2009
Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2009 and Updates 2009 Full Year Guidance |
|
|
| |
ARDEE, Ireland, May 11, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter ended March 31, 2009. Revenue in the quarter ended March 31, 2009 totaled $246.0 million, an increase of 7.2% over the prior year quarter. The primary drivers of the increase in revenue we... |
|
|
May 7, 2009
Warner Chilcott to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference |
|
|
| |
HAMILTON, BERMUDA, May 7, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will present at the Bank of America and Merrill Lynch Healthcare Conference on Tuesday, May 12, 2009 at 10:00 a.m. ET. Presenting for Warner Chilcott will be Roger Boissonneault, President and Chief Execut... |
|
|
May 1, 2009
Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent |
|
|
| |
HAMILTON, Bermuda, May 1, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have filed a second lawsuit against Mylan Pharmaceuticals Inc. and Mylan Inc. ("Mylan") in the District Court for the District of New ... |
|
|
April 27, 2009
Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2009 Financial Results |
|
|
| |
HAMILTON, Bermuda, April 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will issue its first quarter 2009 financial results prior to the market opening on Monday, May 11, 2009.
In addition to issuing a press release, the Company will host a conference call for all intereste... |
|
|
March 27, 2009
Warner Chilcott Announces NDA Submission for Low Dose Oral Contraceptive |
|
|
| |
HAMILTON, Bermuda, March 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that its affiliate, Warner Chilcott Company Inc. has submitted a New Drug Application for WC 3016, a low-dose oral contraceptive, to the U.S. Food and Drug Administration.
About Warner Chilcott
Warner Chilcott... |
|
|
March 19, 2009
Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent |
|
|
| |
HAMILTON, Bermuda, March 19, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have filed a second lawsuit against Impax Laboratories, Inc. ("Impax") in the District Court for the District of New Jersey for inf... |
|
|
March 17, 2009
Warner Chilcott Announces Receipt of FDA Response to Citizen Petition |
|
|
| |
HAMILTON, Bermuda, March 17, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it has received the FDA's response to its citizen petition requesting that the FDA impose a 30-month stay of approval on Abbreviated New Drug Applications ("ANDAs") referencing DORYX 100 and 75 mg delayed r... |
|
|
March 17, 2009
Warner Chilcott Announces Receipt of Paragraph IV Certification Notice |
|
|
| |
HAMILTON, Bermuda, March 17, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have received a Paragraph IV Certification Notice from Impax Laboratories, Inc. ("Impax") advising that Impax has filed an Abbrevia... |
|
|
February 27, 2009
Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 |
|
|
| |
HAMILTON, Bermuda, Feb 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter and year ended December 31, 2008. Revenue in the quarter ended December 31, 2008 totaled $242.5 million, an increase of 6.5%, over the prior year quarter. Revenue for the year ended De... |
|
|
February 10, 2009
Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2008 Financial Results |
|
|
| |
HAMILTON, Bermuda, Feb 10, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will issue its fourth quarter and full year 2008 financial results prior to the market opening on Friday, February 27, 2009.
In addition to issuing a press release, the Company will host a conference call... |
|
|
February 3, 2009
Warner Chilcott Announces Agreement to Acquire Topical Alprostadil Treatment for Erectile Dysfunction |
|
|
| |
FAJARDO, Puerto Rico and EAST WINDSOR, N.J., Feb 03, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Company, Inc. (a subsidiary of Warner Chilcott, Ltd., [Nasdaq: WCRX]) announced today that it has entered into an agreement with NexMed, Inc. [Nasdaq: NEXM] to acquire the U.S. rights of NexMed's topically applied alprostadil ... |
|
|
January 30, 2009
Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent |
|
|
| |
HAMILTON, Bermuda, Jan 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have filed a lawsuit against Actavis Elizabeth LLC ("Actavis") in the District Court for the District of New Jersey for infringement ... |
|
|
January 27, 2009
Warner Chilcott Announces 2009 Financial Guidance |
|
|
| |
HAMILTON, BERMUDA, Jan 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today a view of anticipated full year 2009 results.
Total revenues for 2009 are expected to be in the range of $1,015 to $1,025 million, with the results primarily being driven by LOESTRIN 24 FE, DORYX, and TACLONEX. G... |
|
|
January 22, 2009
Warner Chilcott Announces 2009 Financial Guidance Conference Call |
|
|
| |
HAMILTON, Bermuda, Jan 22, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will issue its 2009 Financial Guidance after market close on Tuesday, January 27, 2009. In addition to issuing a press release, Roger Boissonneault, President and Chief Executive Officer and Paul Herendeen... |
|
|
January 16, 2009
Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent |
|
|
| |
HAMILTON, Bermuda, Jan 16, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne"), a subsidiary of Hospira, Inc., have filed a lawsuit against Sandoz Inc. ("Sandoz") in the District Court for the District of New Jer... |
|
|
|
Investor Relations
